4.5 Review

REASSURED diagnostics to inform disease control strategies, strengthen health systems and improve patient outcomes

期刊

NATURE MICROBIOLOGY
卷 4, 期 1, 页码 46-54

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/s41564-018-0295-3

关键词

-

资金

  1. Chinese Academy Medical Sciences Initiative for Innovative Medicine [2016-I2M-3-021]
  2. CSIR parliamentary grant funding
  3. UK Engineering and Physical Sciences Research Council (EPSRC) i-sense Early Warning Sensing Systems in Infectious Disease [EP/K031953/1]
  4. EPSRC [EP/K031953/1] Funding Source: UKRI

向作者/读者索取更多资源

Lack of access to quality diagnostics remains a major contributor to health burden in resource-limited settings. It has been more than 10 years since ASSURED (affordable, sensitive, specific, user-friendly, rapid, equipment-free, delivered) was coined to describe the ideal test to meet the needs of the developing world. Since its initial publication, technological innovations have led to the development of diagnostics that address the ASSURED criteria, but challenges remain. From this perspective, we assess factors contributing to the success and failure of ASSURED diagnostics, lessons learnt in the implementation of ASSURED tests over the past decade, and highlight additional conditions that should be considered in addressing point-of-care needs. With rapid advances in digital technology and mobile health (m-health), future diagnostics should incorporate these elements to give us REASSURED diagnostic systems that can inform disease control strategies in real-time, strengthen the efficiency of health care systems and improve patient outcomes.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据